Benzimidazole compounds as c-Kit inhibitors
US11117883B2 · kind B2 · utility
0Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 14, 2017 |
| Grant date | Sep 14, 2021 |
| Priority date | — |
| Expiry date | Feb 3, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to c-Kit inhibitors useful in the treatment of cancers, and other serine-threonine kinase mediated diseases, having the Formula: (I) where A, L, R1, R2, R3, and n are described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.